Dor Yeshorim

Dor Yeshorim
Dor Yeshorim · Public domain · source
Name	Dor Yeshorim
Founded	1983
Type	Non-profit organization
Headquarters	Brooklyn, New York
Founder	Rabbi Josef Ekstein
Key people	Rabbi Yosef Ekstein
Focus	Genetic screening, Tay–Sachs disease, autosomal recessive disorders

Dor Yeshorim is a non-profit organization founded to reduce the incidence of severe autosomal recessive disorders in populations with elevated carrier frequencies through anonymous premarital genetic screening and counseling. The program developed partnerships with rabbinic authorities, medical laboratories, and community institutions to provide confidential compatibility testing and to influence mating choices within endogamous groups. Over decades the organization interacted with medical centers, universities, and communal agencies to expand panels, inform policy debates, and adapt to genomic technologies.

History

The organization was established in the early 1980s by Rabbi Josef Ekstein amid collaborations with clinicians at institutions such as Mount Sinai Hospital, Hadassah Medical Center, and researchers from Columbia University and Mayo Clinic. Early efforts paralleled carrier screening initiatives for Tay–Sachs disease promoted by researchers at Yeshiva University affiliates and laboratories in Jerusalem and New York City. The program’s growth intersected with public health campaigns led by entities like Centers for Disease Control and Prevention and ties to philanthropic foundations including Guggenheim Foundation-type donors and community funds in Brooklyn, Jerusalem, and London. Policy discussions engaged figures connected to Rabbinical Council of America, Agudath Israel of America, and medical ethicists from Harvard Medical School and Johns Hopkins University. As genetic testing technologies evolved, collaborations expanded to include laboratories associated with Johns Hopkins Hospital, Cleveland Clinic, and university research groups at University of Pennsylvania and Tel Aviv University.

Mission and Services

The stated mission emphasizes lowering incidence of severe inherited conditions by offering preconception and premarital carrier screening linked to confidential matchmaking advisories used by community matchmakers and rabbinic counselors. Services have been coordinated with community institutions such as Yesha Council-linked organizations, Bnei Akiva-affiliated youth programs, and vocational bureaus in Brooklyn and Manchester. Clinical partnerships include genetic counseling referrals to centers at Mount Sinai Hospital, Sheba Medical Center, and university clinics at Weill Cornell Medicine and Ben-Gurion University. The organization engages with advocacy and research entities including National Society of Genetic Counselors, American College of Medical Genetics and Genomics, and community health departments in New York City and Jerusalem.

Genetic Screening Program

The program offers anonymous screening for a panel of mutations associated with disorders such as Tay–Sachs disease, Gaucher disease, Cystic fibrosis in certain populations, and other conditions prevalent in Ashkenazi, Sephardi, and Mizrahi communities. Laboratory testing has been performed via clinical labs analogous to those at Quest Diagnostics, Laboratory Corporation of America, and specialized research labs affiliated with Harvard Medical School and Stanford University. The approach uses a registry model that returns only compatibility results to prevent stigmatization; results have been discussed in forums involving scholars from Brown University, Yale University, and Oxford University. The program’s panels expanded in consultation with geneticists from NIH, Emory University School of Medicine, and researchers at Technion – Israel Institute of Technology.

Ethics and Controversies

Ethical debates have involved theologians and ethicists from institutions like Hebrew University of Jerusalem, Columbia University, Rutgers University, and Georgetown University. Critics from bioethics centers at University of Pennsylvania and Loyola University Chicago raised concerns about anonymity, informed consent, and community pressure, while proponents cited precedents from community-based programs linked to American Jewish Joint Distribution Committee and public health successes akin to Salk polio vaccine campaigns. Controversies intersected with discussions in venues such as panels hosted by World Health Organization-aligned conferences and symposia at Royal Society-sponsored forums, and legal scholars from NYU School of Law and Harvard Law School examined implications for privacy law. Debates also referenced comparative programs addressing hereditary disorders among Ashkenazi Jews, Mizrahi Jews, and other populations studied by investigators at King's College London and University College London.

Impact on Jewish Communities

The program influenced matchmaking practices, premarital counseling, and communal health norms among Orthodox communities in locales including Brooklyn, Monsey, Jerusalem, Bnei Brak, London, Paris, Antwerp, Toronto, and Melbourne. Its role has been noted alongside communal health initiatives involving organizations such as Chabad-Lubavitch, Agudath Israel of America, National Council of Jewish Women, and youth movements like Habonim Dror. Demographic researchers at Bar-Ilan University, Hebrew University, and Tel Aviv University have studied its epidemiological effects, while sociologists from Princeton University and University of Chicago examined cultural ramifications. The program’s model inspired analogous screening frameworks in other faith and ethnic communities studied by scholars at Stanford University and Duke University.

Organizational Structure and Funding

The nonprofit model has relied on community donations, grants, and laboratory fees, involving donors and institutions such as local philanthropic trusts, community federations like Jewish Federations of North America, private foundations, and occasionally municipal health departments in New York City and Jerusalem. Governance has included lay boards with ties to communal institutions such as Rabbinical Council of America and administrative cooperation with clinics at Mount Sinai Hospital and university medical centers at Columbia University and Weill Cornell Medicine. Funding and programmatic oversight raised inquiries from public health policy analysts at Brookings Institution and RAND Corporation, while evaluation studies have been undertaken by researchers at Johns Hopkins Bloomberg School of Public Health and Columbia University Mailman School of Public Health.

Category:Genetic screening organizations